Shawn Cross

CIK 1734779 · Chief Financial Officer · last filed 2026-04-24

Shawn Cross is a Chief Financial Officer who has filed 27 SEC Form 4 insider transactions across 3 companies since 2021. The most recent filing, for PCRX, was dated Apr 24, 2026. Across all open-market trades the lifetime net is −$1.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.4M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.42M

Companies

3

Total Filings

27

Lifetime Open-Market Net

-$1.90M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PCRX Chief Financial Officer 105,341 $22.99 $2.42M -$1.52M 7 2026-04-24
Cyclo Therapeutics, Inc. (CYTHW) Delisted Director 136,346 $0.03 $4.4K $0 5 2025-03-03
Applied Molecular Transport Inc. (AMTI) Delisted CEO & Chair of the Board 0 $0.26 $0 -$383.5K 15 2023-12-28

Recent Filings

27 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-04-24 PCRX Mixed -$112.7K EDGAR
2026-04-22 PCRX Mixed -$104.2K EDGAR
2026-02-13 PCRX Grant (A) +49,091 $0 EDGAR
2025-12-11 PCRX Mixed -$215.5K EDGAR
2025-11-13 PCRX Sell (S) −12,060 -$266.4K EDGAR
2025-11-03 PCRX Tax (F) −6,690 -$143.0K EDGAR
2025-03-03 Cyclo Therapeutics, Inc. (CYTHW) Delisted Grant (A) +28,597 $0 EDGAR
2024-11-18 Cyclo Therapeutics, Inc. (CYTHW) Delisted Grant (A) +17,228 $0 EDGAR
2024-11-05 PCRX Grant (A) +75,000 $0 EDGAR
2024-08-20 Cyclo Therapeutics, Inc. (CYTHW) Delisted Grant (A) +9,028 $0 EDGAR
Showing 110 of 27
Page 1 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.